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A Systematic Mapping Study on the Risk Factors Leading to Type II Diabetes
Mellitus
Abstract
Diabetes is one of the most common diseases that has had devastating effects on the general
population. It is also among the most popular research trends in modern medicine. Thus, due to the
complexity and desirability of this particular affliction, there is a lot of demand towards understanding this
disease better, so that it can pave the way towards better solutions in combating diabetes. The aim of this
review is to provide a categorization of the risk factors leading to Type II Diabetes. In order to provide a
justification for the type of diabetes, an explanation is provided which covers the other types of diabetes
and their relative infliction rate. Once the basics understanding of diabetes established, the various
aspects that increase the risk of Type II Diabetes (T2D) can be classified. Several different facets are
studied in order to come up with a novel classification of the disease. The classification divides the risk
factors into sociodemographic and pathophysiological attributes. The major affecting attribute is
identified to be genetics, as it is intertwined with other attributes. With the use of bioinformatics,
advanced gene sequencing techniques can be applied that would enable the identification of patterns
more closely affecting Type II Diabetes. These patterns can be cross-analyzed with pre-existing
conditions in order to identify similarities and possible risk factors from other diseases. Ultimately, this
classification provides a deeper understanding of the factors affecting Type II Diabetes.
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1. Introduction
Diabetes mellitus is a disease comprised of a group
of symptoms, which have been observed and identified
since the early days of medicine [1]. The first reported
observation of these symptoms was over 3000 years
ago in Egypt [2]. Over the last few millennia the disease has been studied more intensely, and its definition
and related sub-categories have since expanded. The
main breakthrough was during the 18th century when
chemistry was used as a diagnostics tool [3]. New
discoveries were made in every century that allowed
for a better understanding of the disease. However,
each time there were new identifiers or causes that
were contributing to its risk factor. Even though the
disease has been studied for nearly four millennia,
there is no documented evidence report the cure
discovered types of diabetes. Better diagnostic tools
have allowed us to discover the widespread affliction
of this disease. Based on the renal data reported from
US, there is an indication that the disease is only
growing and becoming more widespread [4,5]. Other
countries have also reported to having a similar rate of
increase in diabetic cases [6].
Although there are several types of diabetes, Type II
Diabetes is considered to be the most prevalent. Thus,
identifying its contributing factors becomes an essential step towards finding preventative measures and
treatments for hindering the growth of the disease [7].
There are several existing reviews that aim to
identify risk factors based on a specific criterion
[8e10]. However, there is a lack of studies that collects
information from different aspects of the disease,
which would ultimately provide a better overview of
the interlaying factors and their relationships with one
another. Thus, the aim of this study is to perform a
systematic study that collects most of the relevant
material addressing the issue of Type II diabetes. This
systematic categorization is set apart by the fact that it
collects data on both physiological and sociological
factors that are reported to affect the disease. These
studies are then each analyzed and then synthesized
into a collective categorization which aids in understanding the disease better.
This paper is structured by first focusing on the
main classifications of diabetes, and understanding the
prevalence of each type. The section that follows
would then focus on proposing a classification for Type
II Diabetes, which is considered to be the most

prevalent type of the disease. Once all the factors are
laid out, a discussion takes place on understanding and
connecting the various factors identified and collected.
Finally, a conclusion is made based on the analyzed
information.
2. Diabetes classification
Diabetes refers to a group of metabolic disorders
characterized by high blood glucose levels resulting
from defects in insulin secretion, insulin action, or both
[11]. In 1936, Himsworth conducted research that ultimately led to the separation of debates types [12].
Diabetes mellitus has become one of the most
researched diseases in medical history, due to its
prevalence and lack of a concrete cure [5].
Traditionally, diabetes is divided into two types
(Type 1 and Type 2) [13]. However, the disease is far
more complex than that, and it can manifest differently,
based on a different set of contributing factors. Thus,
the separation and distinction are important in order to
concentrate and focus the efforts regarding its identification and subsequent treatment [14]. However, some
of these have overlapping symptoms or conditions. For
the sake of simplicity, we categorize diabetes into five
categories. The main two categories are Type 1 and
Type 2 Diabetes (T1D and T2D) [15]. Genetic based
diabetes such as Maturity onset diabetes of the young
(MODY) and others such as Latent Autoimmune
Diabetes of Adulthood (LADA) are among the other
sub categories of diabetes [16,17]. There are also other
lesser-known categories such as Type 3 Diabetes that is
unique to women during their pregnancy [18]. These
categories are depicted and classified in Fig. 1.
Fig. 2 illustrates the percentage of each of these
types and a broad view of how prevalent they are
relative to one another. Based on the observed percentages, T2D is the most prevailing form of diabetes,
which encompasses almost 80% of the reported cases.
This form of diabetes one of the most public long-term
endocrine disease is Type 2 Diabetes Mellitus (T2DM),
which characterized by hyperglycemia resulting from
reduced insulin emission and/or insulin resistance [19].
There are observations that related T2D towards the
increase of obesity around the world. The rate of
obesity (defined as an individual with a BMI higher
than 25), has increased by 60% in the last 30 years in
the UK among males older than 15 years of age [20].
The increase in obesity has environmental and social
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Fig. 1. A Types of diabetes and classification.
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Health Statewide Planning and Research Cooperative
System and they were primarily measured by counting
the number of diagnosed patients that had visited any
type of emergency department between the years 2011
and 2015 [26e28]. These results indicate that there an
underlying factor that relates to the prevalence of
diabetes.
3.1. Classification of T2D risk factors

Type 2
Diabetes,
80%

Fig. 2. A pie chart depicting the prevalence ratio of the main types of
diabetes.

impacts, as lives have become more sedentary, but at
the same time, people consume high energy foods filled with simple carbohydrates that ultimately lead to
high-calorie deficit [21e23].
3. T2D contributing factors
There are several aspects of T2D that are required to
be studied in order to fully understand the contributing
factors [24,25]. Some of these aspects relate to the
demography of those afflicted, and others relate to the
physiological aspects of the disease. To gain a better
understanding of the disease on how it operates its
effect on age and race need to be further researched
and observed.
A small controlled sample is observed in Fig. 3,
which illustrates the prevalence of T2D among the
ages of 10e100 in New York City. These observations
were reported by New York State Department of

In order to adequately classify the risk factors
related to Type 2 Diabetes, there needs to be an understanding of its two main related facets. These facets
are rarely addressed or studied together and are often
mentioned or viewed in different instances of research
[29e33]. Thus, the proposed classification divides the
factors into two main groups of sociodemographic attributes and pathophysiological attributes. This classification is illustrated in Fig. 4.
One of the main and biggest factors that are often
overlooked is sociodemographic attributes. This classification refers to several sub-factors such as age,
gender, race, ethnicity, and overall demographic
related attributes. The other facet of this classification
is the pathophysiological which is not separate from
the sociodemographic, but rather a different perspective and focus. This classification focuses on risk factors such as genetics, thyroid abnormality, and insulin
resistance, among others.
3.1.1. Race
There are several studies that indicate race as one of
the several sociodemographic factors that have an effect
on the susceptibility of T2D [25,34e36]. This is further
reinforced in Fig. 3 which encompasses Asians under
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Fig. 3. Estimate prevalence of Type 2 Diabetes between ages 10 to 100 years in New York City from 2011 to 2015.

Fig. 4. Type 2 Diabetes Risk Factors.

the people of color average, which indicates to have a
higher risk of Type 2 Diabetes than white Americans.
This could be attributed to cultural differences between
the races, as some consume certain food groups more
than the others. There is also the fact that genetics plays
a role in the disease, as some races are more susceptible
to certain diseases than others [37e40].

percentage of people with Type 2 Diabetes. This can be
caused by many factors; one such phenomenon is that
patients with Type 2 Diabetes usually do not survive
longer than 80 years old. However, maintaining a
healthy lifestyle makes one less susceptible to the
disease, and thus, disproportionately allows for a lower
percentage of Type 2 Diabetes [44].

3.1.2. Age
Regarding age, there is an indication that as the age
rises, the number and percentage of people inflicted
with Type 2 Diabetes have also increased [41e43].
However, upon closer inspection, it is clear that at
some point there is a fall off. The age that the chart has
shown (Fig. 3) to have the highest susceptibility age at
80 years old for people of color, and 75 for people with
white skin. After this age, there is a decline in the

3.1.3. Gender
Regarding gender, research has shown the men are
more susceptible to Type 2 Diabetes than women [45].
This has mainly pathophysiological reasons which are
further discussed in the related sections. However, to
illustrate the difference, Fig. 5 shows the main percentage which is 65% for biological males and 35% for
biological females. This means that men are more at
risk of Type 2 Diabetes than women [46].
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contribute to the etiology of diabetes and raise the
possibility that either leptin or downstream targets of
leptin may have therapeutic potential for the treatment
of diabetes [59,60].

Fig. 5. Gender ratio on Type 2 Diabetes.

3.1.4. Others
There are some other contributing sociodemographic attributes such as occupation, religion, and
other lifestyle matters which also heavily impact the
risk of Type 2 Diabetes. However, they are not the
main focus of this study [47,48].
3.1.5. Genetics
There are several established kinds of research that
indicate that genetics has a major role in the development of T2D. However, the degree of its effects is
under research, as some have a claim it to have as
much as 80% effective when it comes to heritability,
while others have concluded that the effects of genetics
are as low as 25% [49e51]. However, regardless of this
issue, the facts are clear that genes are extremely
important when it comes to their effect on T2D.
3.1.6. Thyroid abnormality
The most common endocrine disorders are
Dysfunction of the thyroid gland and carbohydrate
metabolism such as diabetes mellitus (DM) and prediabetes [52]. The prevalence of thyroid dysfunction in
T2D patients was reported to be 12.3% in Greece and
16% in Saudi Arabia [53,54]. The higher the flowing
levels of insulin because expanded thyroid multiplication. And the clinical appearances are the bigger
thyroid volume and the arrangement of knobs. In this
manner, the thyroid organ gives off an impression of
being another casualty of the insulin opposition disorder [55e57].
3.1.7. Leptin dysfunction
Another sub-factor is the effect of Leptin. Leptin
discovered in 1994 as a regulator of body weight and
energy balance that produced mainly in the adipocytes
of white adipose tissue [58]. There is a suggestion that
defects or dysfunction in leptin signaling may

3.1.8. Insulin resistance
A variety of clinical disorders are accompanied by
increased fasting plasma insulin concentrations Insulin
resistance (IR) and impaired insulin secretion is a
distinctive characteristic in Type two diabetes mellitus
[61]. The presumption was made, based on many
studies of Caucasian subjects, that insulin resistance
triggers T2D, which is compensated originally by the
increased b-cell response, which finally causes T2D
due to the collapse of pancreatic b-cells [49,52,62].
Insulin resistance occurs before decreased insulin
production and needs to be identified early, by one of
the methods to measure insulin resistance
[50,51,63,64].
3.1.9. Micronutrient deficiency
The lack of supplements and nutritional elements in
the body has been shown to cause complications that
can lead to several underlying conditions in the body
[65]. For instance, there is an established relationship
between vitamin deficiency and obesity, which in turn
has a direct impact on diabetes and insulin resistance
[66]. Among the current researches published, it has
been established that Vitamins A, C, D, and E have the
highest impact on diabetes, while minerals such as
Zinc, Copper, Selenium also seem to be related to insulin regulation and thus affect diabetes in some shape
[67].
The impact of micronutrient deficiency on the body
causes effects that inadvertently accelerate diabetes.
This is because of the lack of these minerals and
micronutrients affects the body functions differently,
and causes them to either not function or underperform. This is seen based on the results in Fig. 6, in
which the highest affecting vitamin is Vitamin D,
followed by Vitamin C [68].
3.2. Genome of the type II diabetes
The expression of the genome, are also affected by
The environment thus ultimately the phenotype, via the
epigenome, the phenotype is mutated by epigenetic
modifications of gene expression by mechanisms along
with methylation of DNA, posttranslational modification of histones, or activation of microRNAs, even
though the DNA sequence is not changed. These
changes to the phenotype can be at the point of the
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noted that the INS gene has a direct relation to diabetes
as the gene encodes the insulin hormone. It was
observed that INS gene located on chromosome 11 has
greater susceptibility to mutation with the risk ratio
value of 0.0020, followed by PAX4 gene located on
chromosome 7 with a value of 0.0015 and SUMO4
gene located on chromosome 6 with a value of 0.0014.
The relative risk for the rest of the genes was presented
in Fig. 7. Thus mutation in INS gene may lead to
elevated blood glucose levels [65e68].
Fig. 6. Percentage of people with vitamin deficiency that suffer from
diabetic foot ulcers [68].

4. Discussion and analysis

entire organism, tissue, or cell. It is tempting to theorize that environmental factors such as diet and exercise can change the level of DNA methylation and
thereby cause changes in gene expression until nowadays there is no evidence support that DNA methylation contributes to the increase in T2D.
The risk of SNP is directly relative to the number of
exons as the hazards of exposure for mutations is high.
The risk of SNP is indirectly relative to the length of
the gene since greater length with a higher number of
introns poses a lesser risk of mutation in the proteinencoding. Therefore, the risk for the protein encoding
genes was derived as a ratio of the number of exons to
the length of the gene. insulin hormone which plays a
main role in the utilization of glucose by the peripheral
tissues thus reducing the blood glucose level, it can be

The aforementioned studies confirm the effect of IR
which may lead to DM but still research needed to
detect the parameters which may affect the IR and find
out more about the relationship between these two
disorders which effect on whole metabolic Pathway.
Hyperglycemia, insulin deficiency, and development
of complications can be considered extremes of the
diabetes spectrum which is similar to T1D, and T2D
share a few manifestations in underlying physiology.
However, the genetic degeneration of T1D and T2D
widely differ, with very few T2D susceptibility loci
showing an association with T1D. Notable exceptions
include the Peroxisome proliferator-activated receptor
gamma (PPARG) Pro12Ala variant, Melatonin receptor
1B (MTNR1B), Hepatic Nuclear Factor 1 Alpha
(HNF1A), Family Zinc Finger 3 (GLIS3), 6q22.32 and

Fig. 7. Relative risk factor for the protein encoding genes. Risk factors were calculated as ratio of number of exons to gene length.
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novel loci near the (major histocompatibility complex)
MHC, which harbor the (human leukocyte antigen)
HLA class II genes associated with about half the T1D
risk [65e67,69]. Based on these studies, the mechanisms underlying T1D and T2D appear to be alone
distinct. The distribution of T2D risk SNPs should be
more random in a T1D patient; however, this does not
seem to be the case. The protection from T1DM by
strongest T2D-SNP in the TCF7L2 gene. T1D risk
variants for BCAR1, GLIS3, and RAD51L1 were protective for T2D whereas, for those in C6orf173, COBL,
and C10 or f59, the effects were coincident [70]. Also, it
has been reported that APOC3 haplotypes increase the
risk of T1D; however, the same variants increase the risk
of T2D in lean carriers while having a protective effect
in overweight carriers [71]. Common variants in
SLC30A8 are associated with an increased risk of
TYPE 2 DIABETES, and rare variants with a protective
effect [72,73]. In new-onset T1D patients, a mystery
was also found, SLC30A8 be a major autoantigen
trigger 60%e80% autoantibodies [74].
As for micronutrient deficiency, there is a major
indication that both the lack of certain vitamins and
minerals can increase the risk of getting diabetes [75].
Both due to the direct and indirect effect of these
elements.
Vitamin D deficiency was the most common deficiency observed, and based on the results of previous
studies it seems to be a major factor [76]. However,
there are several possibilities that would explain this
phenomenon. Most of the studies that measured
Vitamin D deficiency were performed on diabetic patients. In a study conducted among 912 subjects (429
T2D cases and 483 non-diabetic control), it was found
that Vitamin D deficiency was reported in T2D
(91.4%) and nondiabetic subjects (93.0%), its role in
hemoglobin glycation and IR could not be established
[77]. It is worthy of note that depletion in Vitamin D
status might not only be an indicator of ill health but
could also be an indicator of the individual lifestyle
pattern ranging from indoor working with restriction to
sunlight exposure, low visibility, and poor dietary
habits. In addition, Vitamin D deficiency was found to
affect insulin synthesis and secretion in human/animal
models of DM, suggesting its role in the etiology and
pathogenesis of both types of DM [78].
Typically, in people with obesity, there is a tendency
of less physical exercise and thus, there are reported to
get a lesser value of Vitamin D from the Sun. This
ultimately affects the system negatively, as the lack of
mobility ultimately leads to further complications and
issues. The importance of Vitamin D remains of

undisputed importance for Diabetes. Thus, the deficiency is considered to be one of the more critical risk
factors.
Zinc, Selenium, and Iron have also had several
studies conducted on them, which ultimately concluded
that both Zinc and Selenium have the highest effect on
diabetes, as these minerals are used for the synthesis of
certain proteins in the body that ultimately regulates
insulin [79]. Thus, their existence is necessary, and
therefore, the lack of them can increase the risk of
diabetes. Most interestingly studies indicate that supranutritional Selenium intake and high plasma Se levels
are possible risk factors for the development of T2D,
pointing to adverse effects of Se on carbohydrate
metabolism in humans. Also, an increase in plasma Se
levels might be a consequence and cause of diabetes.
Besides Selenium, a number of metal ions (vanadium,
copper, zinc, and cadmium) are known to trigger insulin-mimetic effects by activating AKt and other kinases
of the insulin signaling cascade such p70S6. It is
postulated that PGC-1a serves as its molecular switch
linking Se and carbohydrate metabolism [80].
5. Conclusion
In conclusion, a systematic study was conducted
on the risk factors (also known as contributing factors) behind Type 2 Diabetes. This answered two main
questions. First, to categorize the different types of
diabetes. This was done by performing and in-depth
study on the various aspects of diabetes, and it was
concluded that there are generally two main categories and several other smaller categories. Type 2
Diabetes was the most inflicted among all. Hence, the
focus is shifted towards this type of diabetes. The
second research question focused on categorizing the
main risk factors behind Type 2 Diabetes. Through
extensive research and review, two categories were
proposed. Sociodemographic, and pathophysiological
attributes. Sociodemographic attributes focused on
collective issues such as age, gender, race, and others
which heavily influenced the prevalence of having
Type 2 Diabetes. Men for instance were more prevalent than women, which were disproportionately
affected by the disease. The race also played a main
role, however, this could have cultural and lifestyle
implications, rather than racial genetics. The next
category of pathophysiological attributes focused on
internal issues, such as hereditary factors (genetics),
insulin resistance, thyroid abnormality, and leptin
dysfunction. These were each study and presented
with related papers and references.
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The two most important attributes that increase the
risk factor of Type 2 Diabetes were Genetics and
Micronutrient Deficiency. Genetics enables pre-existing conditions that were observed in race, gender, and
environment to have effects on human physiology,
which ultimately would make certain bodies more
susceptible to Diabetes. Micronutrient deficiency also
indicated that the lack of certain vitamins, such as
Vitamin D, could have a huge effect on the occurrence
of Diabetes, as this vitamin is responsible for the
synthesis of certain proteins inside the body that can
lead to obesity and diabetes if not balanced and
addressed. Same with certain minerals such as selenium and zinc, which are required for your body to
synthesize insulin, and a deficiency in them can cause a
chain reaction, which ultimately leads to Type 2 Diabetes, as well as some other complications.
These were ultimately the main findings of this
systemic review and categorization. This form of categorization and classification would allow future researchers to focus their efforts on certain aspects of the
risk factors and identify all related issues that stem from
their existence. Using bioinformatics and, advanced
gene sequencing techniques can be applied that would
enable the identification of patterns more closely
affecting T2D. These patterns can be cross analyzed
with pre-existing conditions in order to identify similarities and possible risk factors from other diseases.
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